logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 6 of 6 Items
Showing 1 - 6 of 6 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018

Naylor-Leyland G, Collin SM, Gatluak F, den Boer ML, Alves F,  et al.
2022-08-18 • PLOS Neglected Tropical Diseases
2022-08-18 • PLOS Neglected Tropical Diseases
BACKGROUND
Visceral Leishmaniasis (VL) is endemic in South Sudan, manifesting periodically in major outbreaks. Provision of treatment during endemic periods and as an emergency respo...
Journal Article
|
Research

A comparison of the effectiveness of sodium stibogluconate monotherapy to sodium stibogluconate and paromomycin combination for the treatment of severe post kala azar dermal leishmaniasis in South Sudan - A retrospective cohort study

Abongomera C, Gatluak F, Buyze J, Ritmeijer KKD
2016-09-22 • PLOS One
2016-09-22 • PLOS One
BACKGROUND
Post-kala-azar dermal leishmaniasis (PKDL) is a common dermatological complication following successful treatment of Visceral Leishmaniasis (VL) caused by Leishmania donov...
Journal Article
|
Research

A clinical severity scoring system for visceral leishmaniasis in Immunocompetent patients in South Sudan

Kamink SS, Collin SM, Harrison TS, Gatluak F, Mullahzada AW,  et al.
2017-10-02 • PLOS Neglected Tropical Diseases
2017-10-02 • PLOS Neglected Tropical Diseases
BACKGROUND
South Sudan is one of the most endemic countries for visceral leishmaniasis (VL), and is frequently affected by large epidemics. In resource-limited settings, clinicians r...
Journal Article
|
Research

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan

Pekelharing JE, Gatluak F, Harrison TS, Maldonado F, Siddiqui MR,  et al.
2020-01-24 • PLOS Neglected Tropical Diseases
2020-01-24 • PLOS Neglected Tropical Diseases
INTRODUCTION
Visceral leishmaniasis (VL) is endemic in South Sudan, where outbreaks occur frequently. Because of changes in the immune system during pregnancy, pregnant women are con...
Journal Article
|
Research

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends

Gorski S, Collin SM, Ritmeijer KKD, Keus K, Gatluak F,  et al.
2010-06-08 • PLOS Neglected Tropical Diseases
2010-06-08 • PLOS Neglected Tropical Diseases
BACKGROUND: Risk factors associated with L. donovani visceral leishmaniasis (VL; kala azar) relapse are poorly characterized. METHODS: We investigated patient characteristics and drug re...
Journal Article
|
Research

Treatment of kala-azar in Southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy

Melaku Y, Collin SM, Keus K, Gatluak F, Ritmeijer KKD,  et al.
2007-07-01 • American Journal of Tropical Medicine and Hygiene
2007-07-01 • American Journal of Tropical Medicine and Hygiene
Médecins sans Frontières-Holland has treated > 67,000 patients with kala-azar (KA) in southern Sudan since 1989. In 2002, we replaced the standard regimen of 30 days of daily sodium stib...